effect of Royal jelly on sexual function in patients undergoing percutaneous coronary interventio
Phase 2
- Conditions
- Ischaemic heart diseases.Ischaemic heart diseases120-125
- Registration Number
- IRCT20180205038626N13
- Lead Sponsor
- Rasht University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- 64
Inclusion Criteria
Cardiac patients undergoing angioplasty in phase 3 of cardiac rehabilitation
Married
Patients with an age range of 20 to 70 years
The score of sexual function questionnaire in men is less than 26 and in women less than 23
Exclusion Criteria
Symptomatic cardiac patients
Candidate for stenting in another vessel
History of urological diseases
History of Viagra drug use
Taking antidepressants
Change in the patient's disease treatment plan during the study?
Changing the type of drugs used, effective factors studied
Reluctance to continue the study or cause any dissatisfaction regarding the consuming royal jelly or participation in the study
Body mass index greater than 35
Taking warfarin
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method